Cronos CRON
NASDAQ CRON
$3.22 -0.07 (-2.13%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cronos (CRON) Divestments (2022 - 2023)

Cronos (CRON) posted quarterly Divestments of -$4000.0 for Q4 2023, down 300.0% quarter-over-quarter from $2000.0 in Q3 2023.

Cronos (CRON) Divestments (2022 - 2023) Analysis & Trends

Cronos' Divestments history runs 2 years deep, the most recent figure standing at -$4000.0 for Q4 2023.

  • In Q4 2023, Divestments changed N/A year-over-year to -$4000.0; the TTM figure through Dec 2024 stood at -$2000.0 (changed 0.0% YoY), while the FY2023 annual figure was $1.3 million, changed N/A from the prior year.
  • Divestments for Q4 2023 stood at -$4000.0, down from $2000.0 in the prior quarter.
  • The five-year high for Divestments was $44000.0 in Q1 2022, with the low at -$44000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 4.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 65.64 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Cronos 1.20 Bn 407.87 Mn 28.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -4,000.00
Sep 30, 2023 2,000.00
Jun 30, 2022 -44,000.00
Mar 31, 2022 44,000.00